On Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- After Ferguson: Stop deferring to the cops
- The hilarious hypocrisy of Republicans complaining about the imperial presidency
- Ferguson riots were terrible — but this racist reaction was worse
- 43 TV shows to watch in 2014
- Don't argue about politics this Thanksgiving. Just don't.
- Is it now OK to have sex with animals?
- 7 grammar rules you really should pay attention to
- In Ferguson, Michael Brown lost his life — and America's police lost the benefit of the doubt
- How to survive a spaceship disaster
- How to be the most productive person in your office — and still get home by 5:30 p.m.
Subscribe to the Week